Cas:1698878-14-6 Nampt-IN-1 manufacturer & supplier

Chemical Name:Nampt-IN-1

CAS.NO:1698878-14-6

Synonyms:2-Hydroxy-2-methyl-N-{2-[(3-pyridinyloxy)acetyl]-1,2,3,4-tetrahydro-6-isoquinolinyl}-1-propanesulfonamide;1-Propanesulfonamide, 2-hydroxy-2-methyl-N-[1,2,3,4-tetrahydro-2-[2-(3-pyridinyloxy)acetyl]-6-isoquinolinyl]-;LSN3154567

Molecular Formula:C₂₀H₂₅N₃O₅S

Molecular Weight:419.495

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:659.9±65.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.624

PSA:

Exact Mass:419.151489

LogP:0.97

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-Hydroxy-2-methyl-N-{2-[(3-pyridinyloxy)acetyl]-1,2,3,4-tetrahydro-6-isoquinolinyl}-1-propanesulfonamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,LSN3154567 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Hydroxy-2-methyl-N-{2-[(3-pyridinyloxy)acetyl]-1,2,3,4-tetrahydro-6-isoquinolinyl}-1-propanesulfonamide Use and application,LSN3154567 technical grade,usp/ep/jp grade.

Related News: Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching. Nampt-IN-1 manufacturer Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection. Nampt-IN-1 supplier The fine and functional chemicals sector provides new growth drivers. Nampt-IN-1 vendor Microarrays of over 5,500 plasma membrane and secreted protein targets are expressed in human cells. Nampt-IN-1 factory Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection.